Gas6 Contributes to the Spread of Calcification in the Aortic Valve
Calcification is a feature of aging in a number of tissues, and perhaps of greatest concern where it occurs in the vasculature and heart. Some cells in the vasculature respond to the aging environment by maladaptively taking on characteristics of the osteoblast cells responsible for building bone tissue. They deposit calcium structures in vascular tissue, a process which progressively hardens blood vessel walls and, most importantly, structures in the heart. Calcification of heart tissue is ultimately fatal. Unfortunately there are no truly effective therapies to turn back the process of calcification of tissues. About the best on offer is EDTA chelation, which does not have very large effects. Prevention is similarly challenging; there is good evidence for supplementation with vitamin K to slow down calcification, but effect sizes are modest and vary from individual to individual for reasons that remain unclear - much the same situation as exists for LDL cholesterol lowering therapies and atherosclerosis.
Calcification spreads through tissue. In today's open access paper, researchers dig into the exact mechanisms responsible for this spread in aortic valves. They identify Gas6 secreted by senescent cells in the valve as one of the signals driving the adoption of calcifying behavior by neighboring cells. This provides a target for the development of therapies that at least slow down calcification, but perhaps not capable of reversal of existing calcification. Following discovery of a relevant signal molecule, one could in principle also target the molecule biochemistry immediately downstream of the signal, but the researchers suggest that in this case these proteins are poor targets for therapy due to their participation in other, vital functions in heart tissue.
Calcific aortic valve disease (CAVD) is an age-associated valvular disorder in which calcification expands from discrete foci into adjacent tissue. We investigated whether mitochondrial-derived vesicles (MDVs) released by human valvular interstitial cells (hVICs) exert pro-calcific effects on recipient cells and how MDV release is regulated. Using ex vivo hemodynamic perfusion of human CAVD tissue, multi-omics profiling, live-cell single-organelle tracking, MDV transfer assays, and in vivo Gas6 deletion, we found that calcifying hVICs hypersecreted MDVs that exerted pro-calcific effects in recipient hVICs.
High-resolution imaging showed that mitochondria remodeled into donut-shaped structures under pro-osteogenic conditions; these structures served as physical platforms for MDV budding. Human CAVD valve tissues and hVICs treated with pro-osteogenic medium also exhibited senescence-associated features. Multi-omics profiling identified growth arrest-specific 6 (Gas6), a senokine, among 36 concordantly upregulated candidates. Functional analyzes showed that Gas6 promoted terminal MDV scission while leaving donut-shaped mitochondrial precursor formation intact. Mechanistically, Gas6 promoted intracellular Ca2+ accumulation, calcium/calmodulin-dependent protein kinase II (CaMKII) activation, and dynamin-related protein 1 (DRP1) phosphorylation, supporting a Ca2+-CaMKII-DRP1 axis that facilitates terminal MDV scission.
Pharmacological inhibition of CaMKII or DRP1 reduced MDV hypersecretion and subsequent recipient-cell calcification, and Gas6 deletion in vivo attenuated valvular stenosis, calcification, and fibrotic remodeling. Neither protein, however, represents a straightforward therapeutic target. DRP1 is needed for normal mitochondrial fission, mitophagy, and quality control; systemic inhibition may therefore disrupt essential mitochondrial functions. CaMKII presents similar challenges. It is active in cardiac excitation-contraction coupling, neuronal plasticity, and immune signaling; these broad physiological roles may complicate systemic inhibition. Gas6 may therefore represent a candidate upstream control point. It lies upstream of CaMKII and DRP1 and is secreted, providing a rationale for evaluating Gas6-directed strategies.